Kunming Biomed International (KBI)
Southwest China pharmacology CRO specializing in nonhuman primate efficacy, PK/PD and exploratory safety studies.
39 contract research organizations in our directory list Pharmacokinetics as a capability, across 11 countries. 29 report GLP capability and 18 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
Showing 39 CROs. Order rotates daily so no lab is permanently listed first.
Southwest China pharmacology CRO specializing in nonhuman primate efficacy, PK/PD and exploratory safety studies.
Nonclinical CRO supporting infectious disease and other in vivo studies; bioanalysis and pathology support.
Preclinical GLP toxicology and safety pharmacology across small and large species.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
South Korea's first private non-clinical CRO, providing GLP toxicity, safety pharmacology, pharmacokinetic and efficacy studies for drugs, chemicals and biologics.
Indian GLP-certified preclinical CRO providing toxicology and safety studies.
Bengaluru-based preclinical CRO, part of Eurofins, offering GLP safety assessment, DMPK and discovery services for pharmaceutical and agrochemical sponsors.
Global preclinical/clinical CRO with extensive safety assessment, pharmacology, and discovery services.
Long-established Japanese preclinical CRO providing toxicology, carcinogenicity, genetic toxicity and pharmacology studies.
Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.
Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.
Houston preclinical CRO near the Texas Medical Center with an AAALAC-accredited mouse vivarium, in vivo pharmacology and flexible lab space.
Translational research company using Old World primate models for ophthalmology, CNS and metabolic disease studies, with an AAALAC-accredited primate facility.
Beijing-based preclinical CRO focused on GLP safety evaluation, with branches across China and support for biologics, nucleic acid and cell and gene therapies.
Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.
CRO providing DMPK, bioanalysis, toxicology, and related preclinical services.
Large CRO with global preclinical safety assessment, DMPK, and bioanalytical services.
Independent Danish CRO focused on early in vivo pharmacology in rodents, with particular expertise in mouse cancer and immuno-oncology models.
Preclinical in vivo pharmacology with CNS/behavioral expertise and multiple disease models.
Preclinical in vivo pharmacology and toxicology with aerosol/inhalation expertise.
Bengaluru preclinical CRO providing pharmacology, pharmacokinetic and toxicology studies.
Florida-based non-clinical CRO providing pharmacokinetic, pharmacodynamic and toxicology studies in nonhuman primates.
Lyon oncology CRO providing in vitro and in vivo proof-of-concept studies for anticancer agents, including resistant tumor models.
Edmonton CRO providing anti-infective drug discovery support, including in vivo infection models and pharmacokinetics.
GLP-accredited preclinical CRO headquartered in Denmark with sites in Sweden, Austria and the UK. Known for Gottingen minipig work and regulatory toxicology, with discovery pharmacology including CNS and…
Preclinical CRO offering discovery, DMPK, toxicology, surgical models, and specialty pathology.
Preclinical CRO offering in vivo pharmacology, toxicology, and surgical services.
Texas preclinical CRO offering xenograft and other oncology models, efficacy, pharmacology and toxicology studies.
Preclinical CRO in West Michigan specializing in targeted CNS delivery. Long track record supporting intrathecal, intracerebroventricular and cisterna magna dosing, CSF and tissue distribution, pharmacokinetics and…
Long-established Japanese CRO with large GLP nonclinical safety facilities and deep nonhuman primate experience, supporting toxicology, safety pharmacology and pharmacokinetics.
Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.
Vertically integrated nonhuman primate CRO in South Carolina combining on-site breeding with discovery pharmacology, GLP toxicology, vaccine and gene therapy studies.
Preclinical CRO with GLP laboratories near Budapest and offices in Munich, offering safety assessment, ADME-PK, bioanalysis and pharmacodynamic models.
Wuhan CRO integrating NHP breeding with toxicity and safety evaluation, PK/PD, molecular imaging and bioanalysis.
St. Louis area CRO providing toxicology, pharmacokinetic and bioanalytical services, including inhalation work.
Preclinical CRO with roots in a Chinese Academy of Sciences safety center, offering pharmacology, DMPK and safety evaluation with GLP operations in Shenzhen.
Integrated CRO/CDMO spanning preclinical to early clinical, including safety assessment and bioanalysis.
French CRO specializing in in vivo infection models for antibacterial and antifungal drug development.
German preclinical CRO offering in vivo pharmacology, pharmacokinetic and exploratory safety studies.